By combining disease expertise with a new single-molecule proteomics technology, scientists at Nautilus and Weill Cornell Medicine hope to unearth new insights into the connection between alpha-synuclein protein and Parkinson’s disease.The post Nautilus, Weill Cornell Team Up to Apply Single Molecule Proteomics Tech to Parkinson’s appeared first on GEN - Genetic Engineering and Biotechnology News.
Nautilus, Weill Cornell Team Up to Apply Single Molecule Proteomics Tech to Parkinson’s
